Eleonora P M Corssmit
Overview
Explore the profile of Eleonora P M Corssmit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1548
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ter Haar S, van Goor S, Corssmit E, van Erkel A, Ballieux B, Dekkers O, et al.
Front Endocrinol (Lausanne)
. 2025 Feb;
15:1497787.
PMID: 39897961
Objective: Primary aldosteronism (PA) is a common cause of secondary hypertension with unilateral and bilateral subtypes requiring different treatments. Adrenal vein sampling (AVS) is the gold standard for subtype differentiation...
2.
Heesters A, Tops C, Potjer T, Corssmit E, Bayley J, Hensen E, et al.
J Neurol Surg B Skull Base
. 2025 Jan;
86(1):1-5.
PMID: 39881751
SDHx variant carriers have an increased risk of developing head and neck paraganglioma. The Dutch guidelines state that these patients require lifelong follow-up, but no clear recommendation is made about...
3.
Lagana M, Habra M, Remde H, Almeida M, Cosentini D, Pusceddu S, et al.
Eur J Cancer
. 2024 Jul;
208:114122.
PMID: 39047533
Metastatic pheochromocytomas and paragangliomas (PPGLs) are frequently associated with skeletal complications. Primary objective: to describe the frequency of adverse skeletal related events (SREs) in PPGL patients with bone metastases (BMs)....
4.
de Jong M, Corssmit E, Jansen J, Potjer T, Bayley J, Hensen E
Case Rep Otolaryngol
. 2024 Mar;
2024:2111531.
PMID: 38549682
Head and neck paragangliomas are slow growing and highly vascular neuroendocrine tumors. It is currently assumed that variants exclusively cause benign and often multicentric head and neck paragangliomas. Here, we...
5.
Feijen M, Palmen M, Lamb H, Corssmit E, Antoni M
Eur Heart J Case Rep
. 2023 Oct;
7(10):ytad418.
PMID: 37811153
Background: Cardiac paragangliomas are extremely rare neuroendocrine tumours derived from neural crest cells that represent <2% of all paragangliomas. Approximately 35-40% of all paragangliomas are associated with inherited syndromes such...
6.
Taieb D, Wanna G, Ahmad M, Lussey-Lepoutre C, Perrier N, Nolting S, et al.
Lancet Diabetes Endocrinol
. 2023 Apr;
11(5):345-361.
PMID: 37011647
Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck paragangliomas, which, in almost 20% of patients, might...
7.
Reichert A, Nies M, Tissing W, Muller Kobold A, Klein Hesselink M, Brouwers A, et al.
Eur J Endocrinol
. 2022 Aug;
187(4):497-505.
PMID: 35947635
Background: Pediatric differentiated thyroid cancer (DTC) has an excellent prognosis but unknown late effects of treatment. The initial cardiac evaluation showed subclinical diastolic dysfunction in 20% of adult survivors. The...
8.
Berends A, Bolhuis M, Nolte I, Buitenwerf E, Links T, Timmers H, et al.
Biomedicines
. 2022 Apr;
10(4).
PMID: 35453646
Background: Presurgical treatment with an α-adrenergic receptor blocker is recommended to antagonize the catecholamine-induced α-adrenergic receptor mediated vasoconstriction in patients with pheochromocytoma or sympathetic paraganglioma (PPGL). There is, however, a...
9.
Steenaard R, Kerkhofs T, Zijlstra M, Mols F, Kerstens M, Timmers H, et al.
Cancers (Basel)
. 2022 Mar;
14(6).
PMID: 35326518
We aimed to develop a disease-specific adrenocortical carcinoma (ACC) health-related quality of life (HRQoL) questionnaire (ACC-QOL) and assess HRQoL in a population-based cohort of patients with ACC. Development was in...
10.
Nies M, Arts E, van Velsen E, Burgerhof J, Muller Kobold A, Corssmit E, et al.
Eur J Endocrinol
. 2021 Sep;
185(6):775-782.
PMID: 34582359
Context: Whilst radioactive iodine (RAI) is often administered in the treatment for differentiated thyroid carcinoma (DTC), long-term data on male fertility after RAI are scarce. Objective: To evaluate long-term male...